首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   47740篇
  免费   4126篇
  国内免费   1649篇
耳鼻咽喉   557篇
儿科学   1484篇
妇产科学   649篇
基础医学   3244篇
口腔科学   910篇
临床医学   4907篇
内科学   7193篇
皮肤病学   665篇
神经病学   1647篇
特种医学   1723篇
外科学   5736篇
综合类   8451篇
现状与发展   4篇
一般理论   3篇
预防医学   4725篇
眼科学   1130篇
药学   4770篇
  33篇
中国医学   2973篇
肿瘤学   2711篇
  2024年   165篇
  2023年   515篇
  2022年   1299篇
  2021年   1855篇
  2020年   1349篇
  2019年   1116篇
  2018年   1215篇
  2017年   1281篇
  2016年   1106篇
  2015年   1613篇
  2014年   2208篇
  2013年   2769篇
  2012年   4064篇
  2011年   4125篇
  2010年   3343篇
  2009年   2814篇
  2008年   3156篇
  2007年   3110篇
  2006年   2798篇
  2005年   2345篇
  2004年   1818篇
  2003年   1448篇
  2002年   1241篇
  2001年   1080篇
  2000年   969篇
  1999年   578篇
  1998年   196篇
  1997年   169篇
  1996年   138篇
  1995年   137篇
  1994年   131篇
  1993年   111篇
  1992年   303篇
  1991年   260篇
  1990年   231篇
  1989年   213篇
  1988年   177篇
  1987年   186篇
  1986年   162篇
  1985年   173篇
  1984年   149篇
  1983年   145篇
  1982年   69篇
  1981年   76篇
  1979年   117篇
  1978年   86篇
  1974年   76篇
  1973年   110篇
  1972年   100篇
  1971年   68篇
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
101.
The effects of the calcium antagonists verapamil and nifedipine on blood glucose levels, glucose tolerance, insulin secretion during glucose tolerance and hypoglycaemic effect of tolbutamide were studied in normal nondiabetic rabbits. Daily dosage of 40 mg/kg verapamil and 5 mg/kg nifedipine given orally up to 7 days did not affect blood glucose level, glucose tolerance, insulin secretion during glucose tolerance and hypoglycaemic activity of tolbutamide 250 mg/kg p.o.  相似文献   
102.
103.
2001~2006年广州市已婚育龄妇女妇女病普查普治情况分析   总被引:1,自引:0,他引:1  
[目的]了解广州市已婚育龄妇女妇女病患病状况,为制订保障育龄妇女生殖健康有效措施提供科学依据。[方法]对2001~2006年广州市妇女病普查普治报表进行分析。[结果]2001~2006年,妇女病检查率平均为50.48%,宫颈细胞涂片率平均为42.56%;妇女病检出率平均为22.82%。妇女病检出率,城区为25.10%,郊区为19.42%(P〈0.01)。宫颈糜烂、子宫肌瘤、宫颈癌检出率分别为9.95%、2.45%、6.40/10万。宫颈糜烂、子宫肌瘤、滴虫性阴道炎的治疗率分别为79.38%、65.58%、86.32%。[结论]广州市已婚育龄妇女妇女病普查率及常见妇女病治疗率较低。  相似文献   
104.
Interleukin 1 (IL-1) and tumor necrosis factor alpha are thought to contribute to the inflammatory response associated with autoimmune diseases. Transforming growth factor beta 1 (TGF-beta 1) counteracts many effects of these cytokines and has various immunosuppressive properties. In the present study, it is shown that microgram amounts of TGF-beta 1, injected daily for 1-2 weeks, protect against collagen-induced arthritis (CIA) and relapsing experimental allergic encephalomyelitis (REAE), the animal models for rheumatoid arthritis and multiple sclerosis, respectively. When administered during induction of the disease, TGF-beta 1 prevents CIA but only delays the onset of REAE by 2-3 days. However, when administered during a remission. TGF-beta 1 prevents the occurrence of relapses in REAE. The results suggest that TGF-beta 1 has powerful anti-inflammatory effects, mimicking in some respects the beneficial effects of immunosuppressive drugs in these experimental models of autoimmune disease, but without discernable adverse effects.  相似文献   
105.
106.
This is a report of a patient on treatment for duodenal tuberculosis, who developed obstructive jaundice due to a benign stricture of the terminal common bile duct. This complication of duodenal tuberculosis, to our knowledge, has not been reported before. Percutaneous, transhepatic balloon dilatation of the stricture alleviated the jaundice.  相似文献   
107.
目的探讨体外循环不同途径给予鱼精蛋白所产生的不良反应及地塞米松对这些不良反应的预防作用。方法将 6 4例患者按给药途径及是否预防性给予地塞米松分为 4组 :A1,A2 ,B1和B2 组。A组升主动脉给药 ,B组颈内静脉给药 ;A1,B1组给予地塞米松 ,A2 ,B2 组不给予地塞米松。观察各组注射鱼精蛋白后 3,10 ,2 0 ,30min平均动脉压 (meanarterialpressure ,MAP)、平均肺动脉压 (meanpulmonaryarterialpressure ,MPAP)及气道压力(airwaypressure ,AP)的变化。结果A1组各时间点数据无显著性差异 (P >0 .0 5 ) ,A2 组给予鱼精蛋白 3min后血压下降 (P <0 .0 5 ) ;B1组给予鱼精蛋白 3min后血压下降 (P <0 .0 5 ) ,气道压力升高 (P <0 .0 5 ) ,B2 组给予鱼精蛋白 3,10 ,2 0min后血压明显下降 (P <0 .0 5 ,P <0 .0 1) ,气道压力升高 (P <0 .0 5 ,P <0 .0 1)。结论从主动脉根部注射鱼精蛋白对血流动力学影响较静脉给药小 ,地塞米松对鱼精蛋白的副作用有一定的预防作用  相似文献   
108.
We present our experience with twenty children with insulin dependent diabetes mellitus admitted during the past 2 1/2 years. Sixteen patients were admited with acute onset of ketoacidosis while four were having gradual onset. Active and symptomatic treatment was started in all diabetic ketoacidotic patients. One patient died during the acute stage. Eleven patients were followed for 3–6 months or more. Glycosylated hemoglobin was considered as a criteria for control. Three had good control, two fair and six poor control; six developed diabetic ketoacidosis and three developed hypoglycemia  相似文献   
109.
Epidemiological studies have indirectly linked compounds ofchromium, nickel and arsenic to human carcinogenesis. However,there is no evidence that metal compounds can transform humancells to the tumorigenic phenotype in culture. We show herethat exposure to 36 µM NiS04 for 48–96 h resultsin transformation of an immortal, non-tumorigenic, osteoblast-likecell line, HOS TE85, to the tumorigenic phenotype. Continuouspassaging following treatment leads to the formation of a fewdense foci. The cells isolated and expanded from the foci aremorphologically transformed, and form anchorage-independentcolonies of the size and abundance comparable to that formedby Kirsten murine sarcoma virus transformed HOS TE85 cells.The transformed cells from tumors in nude mice, have enhancedlevels of plasminogen activators and have lost the ability toform model bone matrix on extended culture in the presence ofascorbic acid and ß-glycerophosphate. A number ofcell lines have been established from nude mouse tumors. Cytogeneticanalysis reveals 16 marker chromosomes and an aberrant chromosome16. This is the first report of the transformation of a humancell line to tumorigenic phenotype by a metal carcinogen.  相似文献   
110.
The value of a prophylactic antibiotic before a routine cystometrogram has been assessed in a controlled trial of 100 patients. The infection rate was low and not statistically different in both groups. Subsequent symptoms of dysuria and haematuria had a mechanical aetiology.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号